Azidothymidine and HIV infection
Offerhaus, L.
Nederlands Tijdschrift Voor Geneeskunde 131(22): 934-936
1987
ISSN/ISBN: 0028-2162 PMID: 3037393 Document Number: 298301
Document emailed within 1 workday
Related Documents
Richman, D.D. 1988: The treatment of HIV infection. Azidothymidine (AZT) and other new antiviral drugs Infectious Disease Clinics of North America 2(2): 397-407Bálint Gábor, S. 1993: Azidothymidine in the management of immune deficiency complex Orvosi Hetilap 134(35): 1921-1925
Mamaeva, O.A.; Pliasunova, O.A.; Pokrovskiĭ, A.G.; Diatkina, N.B.; Arzumanova, A.A. 1994: Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates Molekuliarnaia Biologiia 28(1): 137-142
Inoue, T.; Cronkite, E.P.; Hirabayashi, Y.; Bullis, J.E.; Mitsui, H.; Umemura, T. 1997: Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia Leukemia 11(Suppl 3): 123-127
Mazzei, M.; Balbi, A.; Sottofattori, E.; Bruzzo, C.; Palamone, G.; Nicolin, A. 1990: HPLC determination of azidothymidine (AZT) and its metabolite in human plasma Farmaco 45(6 Suppl): 737-743
Wu, H.-B.; Deng, Y.-H.; Wang, S.-N.; Zhou, X.-Y.; Wang, N.; Shi, L. 2007: The distribution of azidothymidine palmitate galactosylated liposomes in mice Yao Xue Xue Bao 42(5): 538-544
Berlie, H.C.; Berlioux, J.; Daguet, G.L. 1989: Development of HIV 1 antigenemia during treatment with azidothymidine (AZT): follow-up of 90 patients for a year Pathologie-Biologie 37(5 Part 2): 685-689
Anokhin, K.V.; Belotserkovskaia, N.A.; Kraevskiĭ, A.A. 1988: Disordered long-term memory in mice as affected by azidothymidine Biulleten' Eksperimental'noi Biologii i Meditsiny 106(8): 144-145
Mamede, J.A.; Oliveira-Filho, R.M.; Simo s, M.J.; Mora, O.A.; Espiridião SKulay, L. 2000: Hepatic and renal effects of azidothymidine and acyclovir on pregnant rats Clinical and Experimental Obstetrics and Gynecology 27(3-4): 227-230
Bogliolo, G.; Lerza, R.; Mencoboni, M.; Saviane, A.; Pannacciulli, I. 1988: Azidothymidine-induced depression of murine hemopoietic progenitor cells Experimental Hematology 16(11): 938-940
Hermanns-Lê, T.; Gérardy-Goffin, F.; Giet-Lesuisse, M.; Piérard, G.E. 1993: Ultrastructural study of azidothymidine-induced melanoderma in an AIDS patient Annales de Pathologie 13(5): 328-331
Camsonne, R. 1987: Pharmacology of d'-azidothymidine, a clinically active antiretroviral agent against AIDS Therapie 42(6): 562-563
Hartung, H.D. 1992: AIDS encephalopathy--helped by azidothymidine? Primary and secondary cerebral manifestations Fortschritte der Medizin 110(33): 70-71
Lopez-Anaya, A.; Unadkat, J.D.; Schumann, L.A.; Smith, A.L. 1990: Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate Journal of Acquired Immune Deficiency Syndromes 3(11): 1052-1058
Aruna, R.; Jagetia, G.C. 2001: Azidothymidine induces dose dependent increase in micronuclei formation in cultured Hela cells Die Pharmazie 56(6): 492-500
Tosi, P.; Calabresi, P.; Goulette, F.A.; Renaud, C.A.; Darnowski, J.W. 1992: Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo Cancer Research 52(15): 4069-4073
Ganser, A.; Greher, J.; Völkers, B.; Staszewski, S.; Hoelzer, D. 1989: Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS Experimental Hematology 17(4): 321-325
Nishimura, M.; Hidaka, N.; Akaza, T.; Tadokoro, K.; Juji, T. 1998: Differential effect of azidothymidine on resting and activated cells: potentiality of this drug for treatment of post-transfusion graft-versus-host disease Research Communications in Molecular Pathology and Pharmacology 100(2): 131-138
Oskolkova, O.V.; Perepelov, A.V.; Esipov, D.S.; Zamiatina, A.I.; Alekseeva, S.G.; Shvets, V.I. 1997: Synthesis of phosphoceramide azidothymidine and phosphoceramide didehydrodeoxythymidine Bioorganicheskaia Khimiia 23(7): 591-596
Periclou, A.P.; Nandy, P.; Avramis, V.I. 2000: Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT) In Vivo 14(3): 377-388